Suggested by previous studies, using small molecule inhibitors to modulate TNF‐α has the potential for preventing and treating Alzheimer's disease,41 and the increased expression level of iNOS in activated microglia contributes to neurodegeneration.42 The gene discussed is NOS2; the disease is early-onset autosomal dominant Alzheimer disease.